SABS SAB Biotherapeutics, Inc: Earnings per share for the last twelve months
The rolling annual EPS of SAB Biotherapeutics (SABS) demonstrates volatility, with the parameter value equal to -1.68, which correlates with regulatory timeline uncertainty and grant dependency. The business foundation relies on in-house antibody synthesis while delegating final testing to vendors. Meanwhile, the breakthrough pipeline for creating human polyclonal proteins via GMO animals significantly accelerates the fight against viruses.
Analytical breakdowns and data insights for company SAB Biotherapeutics Inc. (SABS)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital SAB Biotherapeutics|SABS - Long-Term Liabilities to Capital|Short-Term Debt to Equity SAB Biotherapeutics, Inc|SABS - Company Total Debt Obligations|Debts to Book Capitalization SAB Biotherapeutics, Inc.|SABS - Company Long-Term Debts|Company Short-Term Debts SAB Biotherapeutics|Quick Liquidity Indicator sabbiotherapeutics.com
- earnings and valuation multiples indicators:
SABS - Final Profit|Projected Future Earnings SAB Biotherapeutics|SABS - Price to Earnings Ratio|Forward P/E Multiple SAB Biotherapeutics, Inc.|SABS - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc.|SABS - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months SAB Biotherapeutics|SABS - Earnings per share for the last four quarters|Quarterly EPS earnings growth sabbiotherapeutics.com|SABS - Earnings per share increase in current year|Earnings growth forecast for next year SAB Biotherapeutics
- sales and revenue data:
Fundamental company analysis:SAB Biotherapeutics (SABS)
Assessing the operational strength of assets requires an analysis of the actual return per share of capital. SAB Biotherapeutics (SABS) minimizes risks through the development of antibodies to combat diabetes and viruses. The annual earnings per share (EPS) figure aggregates data over 12 months, excluding quarterly anomalies. This metric allows for the identification of overvalued quotes relative to actual profits. The stability of this indicator confirms the effectiveness of the innovative drug development platform.
Competitors of SAB Biotherapeutics (SABS)
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|AUPH - Earnings per share for the last twelve months|Net earnings per share for the last four quarters BioCryst Corp BCRX|VERA: Net earnings per share (EPS TTM)|dianthustx.com (DNTH) - Net earnings per share (EPS TTM)|PHVS (Pharvaris) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months ABCL|Net earnings per share for the last 12 months TRML (Tourmaline Corp)|PGEN (Precigen Corp) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|nektar.com - Earnings per share for the last twelve months|Upstream Bio - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Zenas Bio ZBIO|Immunome Corp (IMNM) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Gossamer Bio Corp. (GOSS)|Net earnings per share for the last 12 months KALV|SEPN (septerna.com) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) PVLA|SVRA (Savara Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) RIGL (Rigel Pharmaceuticals Inc)|AnaptysBio Inc. (ANAB) - Net earnings per one share for the last twelve months|ATXS - Earnings per share for the last twelve months|Earnings per share for the trailing year ENGN (engene.com)|RAPT: Net earnings per share (EPS TTM)|Aerovate Therapeutics (JBIO) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Aclaris|Kyverna Therapeutics, Inc - Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) TLSA|CABA - Net earnings per one share for the last twelve months|Ventyx Biosciences, Inc. - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) Theratechnologies, Inc. THTX|AVTX: Net earnings per share for the last 12 months|Eledon Pharmaceuticals, Inc - Earnings per share for the last four quarters|AGEN: Net earnings per share (EPS TTM)|CLYM - Net earnings per share for the last four quarters|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months aTyr Pharma Inc (ATYR)|Earnings per share for the last twelve months Adagene (ADAG)|Net earnings per share for the last four quarters ikenaoncology.com|Earnings per share for the last twelve months Shattuck Labs STTK|Net earnings per share for the last four quarters Equillium Inc (EQ)|Connect Pharma - Net earnings per share (EPS TTM)|IMUX - Net earnings per share (EPS TTM)|ATRA: Net earnings per share (EPS TTM)|IFRX (InflaRx) - Earnings per share for the last twelve months|Earnings per share for the last twelve months X4 Pharmaceuticals|Adicet (ACET) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Celularity Inc. (CELU)|INMB: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) BRNS (Barinthus Bio)|Earnings per share for the trailing year KZR|Akari Therapeutics - Net earnings per share (EPS TTM)|ENLV - Net earnings per share (EPS TTM)|q32bio.com (QTTB) - Earnings per share for the last twelve months|GeoVax Labs - Earnings per share for the trailing year|Earnings per share for the last twelve months Edesa|Net earnings per share for the last 12 months iBio Corporation (IBIO)|Net earnings per share (EPS TTM) CARM|Net earnings per share (EPS TTM) xtlbio.com (XTLB)|Bolt Biotherapeutics, Inc. - Net earnings per share for the last 12 months|Earnings per share for the trailing year HCWB|Aptevo - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters AIM ImmunoTech, Inc. AIM|aditxt.com (ADTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months gribio.com|Earnings per share for the last twelve months XORTX Therapeutics|Net earnings per share for the last 12 months Vyome Holdings Inc. (HIND)|Net earnings per share for the last 12 months REVB (Revelation Bio)|Net earnings per share (EPS TTM) Indaptus Corp (INDP)|Earnings per share for the last twelve months Scinai Immunotherapeutics SCNI|CALI: Earnings per share for the last 12 months|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Allakos Inc.|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|IGMS - Net earnings per share for the last four quarters|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) oceanbiomedical.com|Net earnings per share (EPS TTM) TCBP|Earnings per share for the last twelve months THRD (Third Harmonic Bio Inc.)
